NCT04542135 2025-06-03
Sulindac and Breast Density in Women at Risk of Developing Breast Cancer
Stony Brook University
Phase 2 Completed
Clinical Trials
9 trialsNCT01761877 2023-02-10
NSAID Effects on Clinical and Imaging Breast Biomarkers
Stony Brook University
Phase 2 Completed
NCT00068419 2020-02-19
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Children's Oncology Group
Phase 2 Completed
NCT00841204 2017-12-26
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00335504 2017-02-15
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT01187901 2016-06-17
FAPEST
University of Utah
Phase 2 Completed
NCT00755976 2014-12-31
Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma
Cancer Trials Ireland
Phase 2 Completed
NCT00368927 2014-05-23
Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00039520 2014-05-06
Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
Fox Chase Cancer Center
Phase 2 Completed